Catalyst Pharmaceuticals, Inc. (CPRX) Financials

$21.62

south_east
-$0.43 (-1.95%)
Day's range
$21.35
Day's range
$22.27
$400M$400M$300M$300M$200M$200M$100M$100M$0$0-$100M-$100MEarning201720172018201820192019202020202021202120222022202320232000%2000%0%0%-2000%-2000%-4000%-4000%-6000%-6000%-8000%-8000%Profit Margin
Profit Margin
Revenue
Earnings

CPRX Income statement / Annual

Last year (2023), Catalyst Pharmaceuticals, Inc.'s total revenue was $398.20 M, an increase of 85.90% from the previous year. In 2023, Catalyst Pharmaceuticals, Inc.'s net income was $71.41 M. See Catalyst Pharmaceuticals, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $398.20 M $214.20 M $140.83 M $119.07 M $102.31 M $500,000.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $84.53 M $34.39 M $21.88 M $17.04 M $14.76 M $19.92 M $45,689.00 $43,406.00 $34,468.00 $0.00
Gross Profit $313.67 M $179.81 M $118.95 M $102.03 M $87.55 M -$19.42 M -$45,689.00 -$43,406.00 -$34,468.00 $0.00
Gross Profit Ratio 0.79 0.84 0.84 0.86 0.86 -38.84 0 0 0 0
Research and Development Expenses $93.15 M $19.79 M $16.94 M $16.50 M $18.84 M $19.92 M $11.38 M $11.37 M $11.80 M $10.12 M
General & Administrative Expenses $47.02 M $28.71 M $23.48 M $20.67 M $33.58 M $15.88 M $7.30 M $7.91 M $8.60 M $4.47 M
Selling & Marketing Expenses $86.69 M $29.47 M $26.15 M $23.57 M $3.30 M $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $133.71 M $58.18 M $49.63 M $44.23 M $36.88 M $15.88 M $7.30 M $7.91 M $8.60 M $4.47 M
Other Expenses $0.00 $2.88 M $282,000.00 $586,897.00 $1.59 M $1.29 M $454,163.00 $321,612.00 $100,389.00 $76,233.00
Operating Expenses $259.43 M $77.97 M $66.56 M $60.73 M $55.72 M $35.80 M $18.68 M $19.28 M $20.40 M $14.59 M
Cost And Expenses $311.39 M $112.37 M $88.45 M $77.77 M $70.48 M $35.80 M $18.68 M $19.28 M $20.40 M $14.59 M
Interest Income $0.00 $0.00 $282,000.00 $587,000.00 $1.59 M $1.29 M $454,163.00 $321,612.00 $100,389.00 $76,233.00
Interest Expense $0.00 $0.00 $0.00 $0.00 $0.00 $1.29 M $454,163.00 $321,612.00 $100,389.00 $76,233.00
Depreciation & Amortization $32.88 M $1.49 M $484,000.00 $885,317.00 $297,726.00 $37,978.00 $45,689.00 $43,406.00 $34,468.00 $26,574.00
EBITDA $119.69 M $101.84 M $52.39 M $41.30 M $31.82 M -$35.26 M -$18.49 M -$18.03 M -$20.46 M -$13.57 M
EBITDA Ratio 0.3 0.48 0.37 0.35 0.31 -70.59 0 0 0 0
Operating Income Ratio 0.22 0.48 0.37 0.35 0.31 -70.59 0 0 0 0
Total Other Income/Expenses Net $7.70 M $2.88 M $282,000.00 $586,897.00 $1.59 M $1.29 M $267,259.00 $1.21 M $165,394.00 -$917,633.00
Income Before Tax $94.51 M $104.72 M $52.67 M $41.89 M $33.41 M -$34.00 M -$18.41 M -$18.07 M -$20.23 M -$15.51 M
Income Before Tax Ratio 0.24 0.49 0.37 0.35 0.33 -68.01 0 0 0 0
Income Tax Expense $23.10 M $21.64 M $13.19 M -$33.09 M $1.53 M $2.58 M $141,215.00 -$929,543.00 -$99,473.00 $993,866.00
Net Income $71.41 M $83.08 M $39.48 M $74.98 M $31.88 M -$34.00 M -$18.41 M -$18.07 M -$20.23 M -$15.51 M
Net Income Ratio 0.18 0.39 0.28 0.63 0.31 -68.01 0 0 0 0
EPS 0.67 0.8 0.38 0.72 0.31 -0.33 -0.21 -0.22 -0.25 -0.24
EPS Diluted 0.63 0.75 0.37 0.71 0.3 -0.33 -0.21 -0.22 -0.25 -0.24
Weighted Average Shares Out $106.28 M $103.37 M $103.38 M $103.51 M $102.94 M $102.63 M $85.80 M $82.88 M $80.86 M $64.14 M
Weighted Average Shares Out Diluted $113.75 M $111.38 M $107.80 M $106.24 M $106.02 M $102.63 M $85.80 M $82.88 M $80.86 M $64.14 M
Link